PREVAIL I Cluster Vaccination Study With rVSVΔG-ZEBOV-GP as Part of a Public Health Response in Liberia.

MLA

Bolay, Fatorma K., et al. “PREVAIL I Cluster Vaccination Study With RVSVΔG-ZEBOV-GP as Part of a Public Health Response in Liberia.” The Journal of Infectious Diseases, vol. 219, no. 10, Apr. 2019, pp. 1634–41. EBSCOhost, https://doi.org/10.1093/infdis/jiy698.

APA

Bolay, F. K., Grandits, G., Lane, H. C., Kennedy, S. B., Johnson, M. P., Fallah, M. P., Wilson, B., Njoh, W. S., McNay, L. A., Hensley, L. E., & Higgs, E. S. (2019). PREVAIL I Cluster Vaccination Study With rVSVΔG-ZEBOV-GP as Part of a Public Health Response in Liberia. The Journal of Infectious Diseases, 219(10), 1634–1641. https://doi.org/10.1093/infdis/jiy698

Chicago

Bolay, Fatorma K, Greg Grandits, H Clifford Lane, Stephen B Kennedy, Melvin P Johnson, Mosoka P Fallah, Barthalomew Wilson, et al. 2019. “PREVAIL I Cluster Vaccination Study With RVSVΔG-ZEBOV-GP as Part of a Public Health Response in Liberia.” The Journal of Infectious Diseases 219 (10): 1634–41. doi:10.1093/infdis/jiy698.